In addition, SGLT1 may increase ATP concentrations in myocardial cells during myocardial ischemia or hypoglycemia, which alleviates myocardial damage caused by oxidative stress, fibrosis, and ischemia–reperfusion [74,76]. The gene discussed is SLC5A1; the disease is myocardial ischemia.